Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04927650

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening in the Community

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,200 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Female
Age
25 Years – 49 Years
Healthy volunteers
Accepted

Summary

This study examines prevention and early detection of cervical cancer through self-administration screening of patients in Western Uganda. The cervix is the opening of the uterus or womb, which is the organ that supports babies before they are born. There are simple tests that let doctors know whether or not patients have cells that may become cancer. Some of the tests determine whether patients have an increased risk for cervical disease, but they do not actually confirm that they have it: these are called "screening" tests. This study may help researchers determine how to best deliver cervical cancer prevention services using the HPV test.

Detailed description

PRIMARY OBJECTIVES: I. To establish the acceptance and correlates of self-collected human papillomavirus (HPV)-ribonucleic acid (RNA) testing among women in the rural Ugandan community as well as the incidence and determinants of successful completion of the cervical cancer screening cascade from self-collected HPV testing to receipt of results. II. To ascertain the frequency and determinants of successful acquisition of treatment among women who have HPV detected on self-collected swabs in rural Uganda. III. To derive population-based estimates of the prevalence of high-risk HPV and cervical intraepithelial neoplasia (CIN) detected through community-based screening employing self-collected HPV RNA testing in rural Uganda. OUTLINE: Patients receive a specimen kit for collection of HPV samples. Patients complete questionnaire before and after collection HPV samples. Patients may also participate in an interview about general ideas in improving the screening and treatment process. Patients with positive results, undergo treatment for cervical cancer.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHPV testingUndergo collection of cervical samples for HPV testing
OTHERQuestionnaire AdministrationComplete questionnaires

Timeline

Start date
2015-01-08
Primary completion
2026-01-31
Completion
2026-01-31
First posted
2021-06-16
Last updated
2025-04-10

Locations

1 site across 1 country: Uganda

Source: ClinicalTrials.gov record NCT04927650. Inclusion in this directory is not an endorsement.